Share this article
Share this article
ResearchAndMarkets.com s offering.
The Neurovascular Intervention Devices global market is expected to grow at a high single digit CAGR to reach $4,167.4 million by 2027.
Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of neurovascular interventions. As a result of rapid advances, there is the great expansion in the potential therapeutic application for neurovascular diseases.
Neurovascular Interventional devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula. The market is primarily driven by the increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in the aging population, technological advancement, acquisitions and fa
in 2019
The product segment includes distal filters, proximal occlusion filters and distal occlusion filters. The distal filters segment held the highest share of 38.50% in 2019 in the embolic protection devices market. It is due to non-interference with lesion visualization, the ease of use provided by these devices, and the availability of these filters in various specifications.
The cardiovascular diseases segment
dominated the market and valued at USD 375.11 million in the year 2019
The application segment includes peripheral vascular diseases, cardiovascular diseases and neurovascular diseases. Cardiovascular diseases held the highest share of USD 375.11 million in 2019 in the application segment. These are predominantly utilized in cardiovascular procedures, followed by Peripheral Vascular Diseases (PVDs). It is due to the growing geriatric population. The pervasiveness of Cardiovascular Diseases (CVDs) is set to follow an upward inclination to serve the market as cardiova